Identification of direct targets and modified bases of RNA cytosine methyltransferases V Khoddami, BR Cairns Nature biotechnology 31 (5), 458-464, 2013 | 466 | 2013 |
Transcriptome-wide profiling of multiple RNA modifications simultaneously at single-base resolution V Khoddami, A Yerra, TL Mosbruger, AM Fleming, CJ Burrows, BR Cairns Proceedings of the National Academy of Sciences 116 (14), 6784-6789, 2019 | 235 | 2019 |
Pluripotency transcription factor Oct4 mediates stepwise nucleosome demethylation and depletion A Shakya, C Callister, A Goren, N Yosef, N Garg, V Khoddami, D Nix, ... Molecular and cellular biology 35 (6), 1014-1025, 2015 | 67 | 2015 |
Transcriptome-wide target profiling of RNA cytosine methyltransferases using the mechanism-based enrichment procedure Aza-IP V Khoddami, BR Cairns nature protocols 9 (2), 337-361, 2014 | 61 | 2014 |
Inhibitory effects of Lactobacillus salivarius and Lactobacillus crispatus isolated from chicken gastrointestinal tract on Salmonella enteritidis and Escherichia coli growth M Nouri, F Rahbarizadeh, D Ahmadvand, F MOUSAKHANI, ... Iranian Journal of Biotechnology 8 (1), 32-37, 2010 | 31 | 2010 |
Active BRAF-V600E is the key player in generation of a sessile serrated polyp-specific DNA methylation profile S Dehghanizadeh, V Khoddami, TL Mosbruger, SS Hammoud, K Edes, ... PLoS One 13 (3), e0192499, 2018 | 22 | 2018 |
Experimental approaches for target profiling of RNA cytosine methyltransferases V Khoddami, A Yerra, BR Cairns Methods in Enzymology 560, 273-296, 2015 | 15 | 2015 |
High-expression of monoclonal nanobodies used in the preparation of HRP-conjugated second antibody D Ahmadvand, F Rahbarizadeh, VK Vishteh Hybridoma 27 (4), 269-276, 2008 | 14 | 2008 |
SARS-CoV-2 mRNA-vaccine candidate; COReNAPCIN®, induces robust humoral and cellular immunity in mice and non-human primates R Alimohammadi, M Porgoo, M Eftekhary, SH Kiaie, E Ansari Dezfouli, ... NPJ vaccines 7 (1), 105, 2022 | 11 | 2022 |
10th Royan Institute's International Summer School on “Molecular biomedicine: from diagnostics to therapeutics” S Moradi, P Torabi, S Mohebbi, S Amjadian, P Bosma, F Faridbod, ... BioEssays 42 (6), 2000042, 2020 | 11 | 2020 |
Safety and immunogenicity of COReNAPCIN, a SARS-CoV-2 mRNA vaccine, as a fourth heterologous booster in healthy Iranian adults: A double-blind, randomized, placebo-controlled … M Salehi, IA Darazam, A Nematollahi, M Alimohammadi, S Pouya, ... International Immunopharmacology 134, 112192, 2024 | 4 | 2024 |
Time-resolved small-RNA Sequencing identifies microRNAs critical for formation of embryonic stem cells from the inner cell mass of mouse embryos S Moradi, S Guenther, S Soori, A Sharifi-Zarchi, C Kuenne, V Khoddami, ... Stem Cell Reviews and Reports 19 (7), 2361-2377, 2023 | 3 | 2023 |
Poly (A) tale: from a to a; RNA polyadenylation in prokaryotes and eukaryotes A Mofayezi, M Jadaliha, F Zangeneh, V Khoddami Wiley Interdisciplinary Reviews: RNA 15 (2), e1837, 2024 | 2 | 2024 |
Transcriptome-wide profiling of multiple RNA modifications simultaneously at single-base resolution (vol 116, pg 6784, 2019) V Khoddami, A Yerra, TL Mosbruger, AM Fleming, CJ Burrows, BR Cairns PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF …, 2019 | 1 | 2019 |
Effective targeting of CD19 positive primary B-ALL cells using CAR-NK cells generated with mRNA-LNPs H Salehi-Shadkami, M Sedghi, S Tavoosi, M Alimohammadi, ... bioRxiv, 2024.11. 21.624707, 2024 | | 2024 |
Safety and immunogenicity of COReNAPCIN®, a SARS-CoV-2 mRNA vaccine; a randomized, double-blind, placebo-controlled phase 1 clinical trial M Salehi, IA Darazam, A Nematollahi, M Alimohammadi, S Pouya, ... medRxiv, 2023.11. 01.23297898, 2023 | | 2023 |
METHODs IN BRIEF V Khoddami, BR Cairns nature methods 10 (6), 463, 2013 | | 2013 |
Isolation of Lactobacillus salivarius and Lactobacillus crispatus strains from chicken gastrointestinal tract, having inhibitory effect on Salmonella enteritidis and … F Rahbarizadeh, M Nouri, D Ahmadvand, F Moosakhani, E Sadeqzadeh, ... Iranian Journal of Biotechnology (IJB) 8 (1), 2010 | | 2010 |
Over–expression and purification of recombinant nanobodies and preparation of conjugated second antibody against them F Rahbarizadeh, V Khoddami Vishteh, D Ahmadvand Pathobiology Research 10, 0-0, 2008 | | 2008 |
Construction of a new Hygromycin resistant Enhanced Green Fluorescent Protein (EGFP) Fusion vector (pEGFP-Hygro) VV KHODAMI, M FOROUZANDEH, F RAHBARIZADEH, MJ RASAEI, ... | | 2005 |